New pages

5 August 2026

• 13:2613:26, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy case studies (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2613:26, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy future or investigational therapies (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2613:26, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy cost-effectiveness of therapy (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2613:26, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy follow-up and surveillance (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2413:24, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy comparative therapies (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2413:24, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy outcomes and prognosis (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2413:24, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy periprocedural complications (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2313:23, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy procedural technique and intraprocedural imaging (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2313:23, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy pre-procedural imaging and assessment (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2313:23, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy indications and contraindications (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2313:23, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy pathophysiology of gradient reduction (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2313:23, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy patient and anatomic selection (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2213:22, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy historical perspective (hist | edit) [25 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 13:2213:22, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy overview (hist | edit) [10,219 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 11:4611:46, 5 August 2026 Alcohol septal ablation for hypertrophic obstructive cardiomyopathy (hist | edit) [2,106 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{xyz}} '''To view the main page click here.''' {{CMG}}; {{AE}} {{Nehal}} ==Overview== ==Historical Perspective== ==Patient and Anatomic Selection== ==Pathophysiology of Gradient Reduction== ==Type page name here Indications a...")
• 11:1411:14, 5 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) Future Therapies (hist | edit) [20,286 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 11:0911:09, 5 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) Cost-Effectiveness (hist | edit) [8,313 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}} __NOTOC__ ==Cost-Effectiveness== Economic evidence for transcatheter edge-to-edge repair (TEER) in heart failure with reduced ejection fraction and secondary mitral regurgitation is derived predominantly from COAPT-based analyses comparing TEER plus guideline-directed medical therapy (GDMT) with GDMT alone. The results are model-based, payer-specific, and dependent on patient selection, device cost, hospitalization reduction, an...")

3 August 2026

• 19:1919:19, 3 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) Follow-Up and Surveillance (hist | edit) [51,678 bytes] Nehal Eid (talk | contribs) (Created page with "{{CMG}}; {{AE}} {{Nehal}}")
• 19:1019:10, 3 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) natural history, complications and prognosis (hist | edit) [30,115 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ ==Natural history, complications, and prognosis== ===Natural history during guideline-directed medical therapy=== Ventricular secondary mitral regurgitation (SMR) in heart failure with reduced ejection fraction (HFrEF) is a dynamic lesion whose severity may change substantially after optimization of guideline-directed medical therapy (GDMT) and cardiac resynchronization therapy (CRT). In a prospective cohort of 2,254 ambulatory patients with...")

2 August 2026

• 12:3612:36, 2 August 2026 Medical therapy (GDMT optimization before and after M-TEER) (hist | edit) [35 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 12:3612:36, 2 August 2026 Other Imaging Findings / Other Diagnostic Studies (hist | edit) [35 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 12:3512:35, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) Treatment (hist | edit) [24,928 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 12:3512:35, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) imaging and assessment (hist | edit) [30,638 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 12:3312:33, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) procedural Technique and intraprocedural Imaging (hist | edit) [40,124 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 12:3312:33, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) indications and contraindications (hist | edit) [27,602 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Nehal}}")
• 11:5711:57, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) pathophysiology (hist | edit) [29,259 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ ==Pathophysiology== ===Mechanism of ventricular secondary mitral regurgitation=== Ventricular secondary mitral regurgitation (vSMR) results when structurally normal mitral leaflets fail to coapt because of left ventricular (LV) remodeling. The central mechanical abnormality is an imbalance between '''tethering forces'''—apical and lateral papillary-muscle displacement, annular dilation and flattening, and increas...")
• 00:1600:16, 2 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) classification (hist | edit) [17,513 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ ==Classification== ===Classification framework=== Classification of mitral regurgitation (MR) in patients considered for mitral transcatheter edge-to-edge repair (M-TEER) requires three complementary descriptions: * MR etiology and mechanism * MR severity nomenclature * The class of transcatheter intervention and the standardized classification of its result M-TEER is the procedural class; MitraClip and PASCAL are device platforms within that class....")

1 August 2026

• 23:4023:40, 1 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) historical perspective (hist | edit) [27,689 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ ==Historical Perspective== ===Surgical origin and early transcatheter development=== Mitral transcatheter edge-to-edge repair (M-TEER) evolved from the surgical '''Alfieri edge-to-edge repair''', developed in the 1990s. Approximation of the middle portions of the anterior and posterior mitral leaflets created a double-orifice valve; transcatheter systems subsequently reproduced this principle through percutaneous leaflet grasping.<ref name="maisano2011">{...") Tag: Visual edit: Switched
• 22:3422:34, 1 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) overview (hist | edit) [24,419 bytes] Nehal Eid (talk | contribs) (Created page with "===Definition and principle=== '''Mitral transcatheter edge-to-edge repair (M-TEER)''' is a transseptal, catheter-based therapy that approximates the anterior and posterior mitral valve leaflets, restores leaflet coaptation, and creates a double-orifice valve to reduce mitral regurgitation. M-TEER is the procedural term; MitraClip and PASCAL are device platforms.<ref name="ogara2020">{{cite journal |author=O'Gara PT, Mack MJ |title=Secondary Mitral Regurgitation...")
• 19:1719:17, 1 August 2026 Percutaneous mitral repair as treatment in HFrEF (MitraClip/TEER) (hist | edit) [1,639 bytes] Nehal Eid (talk | contribs) (Created page with "__NOTOC__ {{xyz}} '''To view the main page click here.''' {{CMG}}; {{AE}} Person 1, Person 2, Your Name ==Overview== ==Historical Perspective== ==Classification== ==Pathophysiology== ==Causes== ==Type page name here differential diagnosis|Dif...")

29 July 2026

• 22:0422:04, 29 July 2026 Mitral stenosis transcatheter therapy (hist | edit) [23,508 bytes] Sudarshan Srivats (talk | contribs) (Created page with "__NOTOC__ {{CMG}}; '''Associate Editor-In-Chief:''' {{SUD}}; {{Sara.Zand}} Mohammed A. Sbeih, M.D. [mailto:msbeih@wikidoc.org]; Joanna J. Wykrzykowska, M.D. {{Mitral stenosis}} {{SK}} Balloon mitral valvuloplasty, PMBC, percutaneous mitral balloon valvotomy, percutaneous mitral balloon valvuloplasty, PMBV, mitral valvuloplasty, percutaneous mitral valvuloplasty, PMC, percutaneous mitral commissurotomy ==Overview== Percutaneous mitral balloon v...")
• 14:0814:08, 29 July 2026 Thoracic Endovascular Aortic Repair (TEVAR) (hist | edit) [31,272 bytes] Anum Ijaz (talk | contribs) (Created page with " {{CMG}} {{AE}} {{AIJ}} == Overview == Thoracic endovascular aortic repair ('''TEVAR''') is a catheter-based technique for treatment of pathology involving the descending thoracic aorta, including thoracic aortic aneurysm (TAA), complicated and select uncomplicated type B aortic dissection (TBAD), blunt traumatic aortic injury (BTAI), penetrating aortic ulcer, and intramural hematoma. First performed in 1994 and FDA-approved for descending TAA in 2005, TEVAR...") Tag: Visual edit

22 July 2026

• 01:4601:46, 22 July 2026 Percutaneous Intervention for Coarctation of the Aorta (hist | edit) [28,111 bytes] Anum Ijaz (talk | contribs) (Created page with "{{Interventions infobox | Name = Percutaneous Intervention of coarctation of aorta | Image = | Caption = | ICD10 = | ICD9 = {{ICD9proc|39.51}}, {{ICD9proc|39.52}}, {{ICD9proc|39.7}} | MeshID = | OPS301 = | OtherCodes = | HCPCSlevel2 = }} {{Coarctation of Aorta}} {{CMG}} {{AE}} {{AIJ}} ==Overview== Percutaneous treatment of coarctation of the aorta (CoA) comprises balloon angioplasty (BA) and endovascular s...") Tag: Visual edit: Switched